Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Instagram Outage Disrupts Thousands of U.S. Users 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
KIRKLAND, Wash., Aug. 31, 2016 -- Talyst, a market leader in pharmacy automation technology was recently recognized as a Category Leader in pharmacy automation by KLAS Research. As outlined in its most recent Pharmacy Automation report, Talyst was the clear industry leader in 'Minimizing Medication Spending', a key deliverable for any hospital pharmacy automation installation. Additionally, Talyst leads the way in 'Keeping Promises' and 'Avoiding Nickle & Diming', proving Talyst's long-term commitment to operating a customer-focused organization centered on accountability and honesty in its business practices.
"Talyst's pharmacy automation products were created to provide hospital pharmacies with solutions that increase patient safety while positively impacting the bottom line," said Carla Corkern, Chief Executive Officer at Talyst. "The KLAS report results confirm that our commitment to helping our customers succeed is working, and we look forward to continuing our successful partnership with our valued customers moving forward," Corkern added.
Highlights of the KLAS report include more than 90% of customers agree that Talyst 'Keeps Promises' and 85% agree that Talyst 'Avoids Nickel and Diming'. Other categories where Talyst showed industry leadership include, 'Product Works as Promoted', 'Increases Staff Productivity' and 'Overall Product Quality'.
KLAS Research is an independent organization that publishes industry reports designed to assist healthcare organizations in their purchasing and vendor decision-making process. They publish more than 50 vendor-differentiating reports each year, including the Pharmacy Automation report.
To learn more Talyst's results in the KLAS Research report, please visit: Talyst KLAS Report.
About Talyst
Talyst is a leader in pharmacy automation hardware and software solutions. Our products provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2016, Talyst has installed automated solutions in more than 500 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. We offer a powerful software platform with a suite of hardware components to meet your enterprise-wide needs. Follow us on Twitter @Talyst_LLC or visit us at www.talyst.com.
Contact Info
Michael Blondin
Director, Marketing and Sales Operations
425.289.5732
CONTACT: Michael Blondin
Director, Marketing and Sales Operations
425.289.5732
